WVP
ORGO icon

Worth Venture Partners’s Organogenesis Holdings ORGO Stock Holding History

Worth Venture Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-121,858
Closed -$393K – 135
2020
Q1 		$393K Sell
121,858
-46,142
-27% -$198K 0.24% 57
2019
Q4 		$808K Buy
+168,000
New +$1.06M 0.4% 34

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Worth Venture Partners's ORGO Position: Q2 2020 in Review

Worth Venture Partners sold out of Organogenesis Holdings (ORGO) in Q2 2020, closing a stake of 121,858 shares — an estimated $393K sold.

Worth Venture Partners first reported a position in ORGO in Q4 2019 and held it in 2 quarters. The position peaked at $808K in Q4 2019. 50 funds tracked by Wall St. Rank hold ORGO as of Q2 2020.

  • Worth Venture Partners reported no remaining Organogenesis Holdings position as of Q2 2020 after selling out during the quarter.
  • Worth Venture Partners sold 121,858 Organogenesis Holdings shares in Q2 2020, an estimated $393K.
  • Worth Venture Partners first reported a position in Organogenesis Holdings in Q4 2019 and held it in 2 quarters.
  • Worth Venture Partners's Organogenesis Holdings position peaked at $808K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2020.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.